Dr. James G. Corasanti, MD, PhD

Dr. Corasanti practices at Premier Ambulatory Surgery Center in Hamburg, New York.

Dr. Corasanti's NPI, 1750347068, was assigned on April 25, 2006. Dr. Corasanti graduated from State University of New York at Buffalo School of Medicine in 1983. Dr. Corasanti holds New York license 158564-1.

Dr. Corasanti's primary practice is Premier Ambulatory Surgery Center, at 5844 Southwestern Blvd, Hamburg, NY 14075 in Erie County. The practice phone is (716) 348-2759.

Dr. Corasanti's primary practice is Premier Ambulatory Surgery Center in Hamburg, New York. Dr. Corasanti is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is General Physician. Dmand AI also links Dr. Corasanti to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corasanti practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Corasanti's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Corasanti is licensed in New York.

CMS data shows 355 Medicare services from Dr. Corasanti across 8 procedure codes in 2024, for 300 Medicare patients. Medicare paid $36,864 for them.

CMS counts 300 Medicare patients who saw Dr. Corasanti in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Corasanti's median patient age at 61, with 59% women.

In 2024, Dr. Corasanti wrote 398 Medicare Part D claims for 155 patients. 83% of them were for generic drugs. CMS names the drug for 253 of them, across 9 drugs with 11 or more claims each, at $35,240 in total drug cost. In 2023, CMS named 454 claims across 11 drugs.

Dr. Corasanti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Corasanti as offering telehealth. CMS counts 357 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Corasanti, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Corasanti, published from 2010 to 2016. Dr. Corasanti's most frequent co-authors are John T. Cunningham, MD, Evan L. Fogel, MD and John F. Gibbs, MD.

CMS Open Payments shows 112 general payments to Dr. Corasanti from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Pentax of America, Inc. paid the most, $684.

Dr. Corasanti graduated from State University of New York at Buffalo School of Medicine in 1983.